Fundraising September 15, 2024 – October 1, 2024 About fundraising

FDA Approval Summary: Trabectedin for Unresectable or...

  • Main
  • 2017 / 08
  • FDA Approval Summary: Trabectedin for Unresectable or...

FDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline-Containing Regimen

Barone, Amy, Chi, Dow-Chung, Theoret, Marc R., Chen, Huanyu, He, Kun, Kufrin, Dubravka, Helms, Whitney S., Subramaniam, Sriram, Zhao, Hong, Patel, Anuja, Goldberg, Kirsten B., Keegan, Patricia, Pazdur
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-17-0898
Date:
August, 2017
File:
PDF, 556 KB
english, 2017
Conversion to is in progress
Conversion to is failed